Simplex Trading
MIST icon

Simplex Trading’s Milestone Pharmaceuticals MIST Stock Holding History

Simplex Trading’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.6K Sell
54,171
-95,120
-64% -$152K ﹤0.01% 5919
2026
Q1 		$178K Buy
+149,291
New +$261K ﹤0.01% 4432
2025
Q4 		– Sell
-66,920
Closed -$133K – 9462
2025
Q3 		$133K Buy
+66,920
New +$118K ﹤0.01% 5426
2025
Q2 		– Sell
-40,636
Closed -$54.2K – 9316
2025
Q1 		$32K Buy
40,636
+35,994
+775% +$71.6K ﹤0.01% 6189
2024
Q4 		$10K Buy
4,642
+4,428
+2,069% +$7.6K ﹤0.01% 7201
2024
Q3 		$0 Sell
214
-977
-82% -$1.42K ﹤0.01% 9140
2024
Q2 		$1K Buy
1,191
+713
+149% +$1.15K ﹤0.01% 8490
2024
Q1 		$0 Sell
478
-608
-56% -$987 ﹤0.01% 9443
2023
Q4 		$1K Buy
+1,086
New +$2.95K ﹤0.01% 8522
2023
Q3 		– Sell
-3,588
Closed -$11.2K – 9369
2023
Q2 		$10K Buy
+3,588
New +$13.5K ﹤0.01% 7410
2020
Q4 		– Sell
-59
Closed -$395 – 8792
2020
Q3 		$0 Buy
+59
New +$423 ﹤0.01% 8192

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Simplex Trading's MIST Position: Q2 2026 in Review

Simplex Trading reduced its Milestone Pharmaceuticals (MIST) stake by 64% in Q2 2026, selling an estimated $152K and leaving 54,171 shares worth $72.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5919.

Simplex Trading first reported a position in MIST in Q3 2020 and has held it in 11 quarters since. The position peaked at $178K in Q1 2026. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Simplex Trading held 54,171 shares of Milestone Pharmaceuticals worth $72.6K as of Q2 2026.
  • Simplex Trading sold 95,120 Milestone Pharmaceuticals shares in Q2 2026, an estimated $152K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5919 holding.
  • Simplex Trading first reported a position in Milestone Pharmaceuticals in Q3 2020 and has held it in 11 quarters since.
  • Simplex Trading's Milestone Pharmaceuticals position peaked at $178K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.